Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical AdvisorSemaglutide and Tirzepatide: Top 5 Things Clinicians Should Know

From side effect to mechanism of action to patient acceptance to managing insurance hurdles, this collection of expert points from the February Endocrine Society meeting is a helpful synopsis of need-to-know items for PCPs.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form